NS
ABCL icon

NBC Securities’s AbCellera Biologics ABCL Stock Holding History

NBC Securities’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7K Sell
2,000
-6,500
-76% -$31.8K ﹤0.01% 1718
2026
Q1 		$29.7K Hold
8,500
– – ﹤0.01% 1541
2025
Q4 		$29.1K Sell
8,500
-400
-4% -$1.79K ﹤0.01% 1592
2025
Q3 		$44.8K Hold
8,900
– – ﹤0.01% 1376
2025
Q2 		$30K Sell
8,900
-2,000
-18% -$4.98K ﹤0.01% 1525
2025
Q1 		$24K Buy
10,900
+10,889
+98,991% +$31.2K ﹤0.01% 1408
2024
Q4 		$32 Sell
11
-11,409
-100% -$31.8K ﹤0.01% 1101
2024
Q3 		$29K Buy
11,420
+4,100
+56% +$11.4K ﹤0.01% 1350
2024
Q2 		$21K Sell
7,320
-900
-11% -$3.41K ﹤0.01% 1431
2024
Q1 		$37K Buy
8,220
+500
+6% +$2.55K ﹤0.01% 1216
2023
Q4 		$44K Buy
7,720
+1,000
+15% +$4.63K ﹤0.01% 1161
2023
Q3 		$30K Buy
+6,720
New +$40.9K ﹤0.01% 1285

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

NBC Securities's ABCL Position: Q2 2026 in Review

NBC Securities reduced its AbCellera Biologics (ABCL) stake by 76% in Q2 2026, selling an estimated $31.8K and leaving 2,000 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

NBC Securities first reported a position in ABCL in Q3 2023 and has held it in 12 quarters since. The position peaked at $44.8K in Q3 2025. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • NBC Securities held 2,000 shares of AbCellera Biologics worth $15.7K as of Q2 2026.
  • NBC Securities sold 6,500 AbCellera Biologics shares in Q2 2026, an estimated $31.8K.
  • AbCellera Biologics made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1718 holding.
  • NBC Securities first reported a position in AbCellera Biologics in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's AbCellera Biologics position peaked at $44.8K in Q3 2025.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.